Net shares · 90d
-40.8K
0 buy · 40.8K sell
Net value · 90d
-$196.7K
$0 in · $196.7K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
14
0 buy · 40.8K sell
Net buy / sell volume (all companies)
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
Show open-market only-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$24.8K
5.0K sh · $4.95
Own -2%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$24.8K
5.0K sh · $4.95
Own -2%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$2.8K
608 sh · $4.61
Own -0%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$23.3K
5.0K sh · $4.67
Own -2%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$24.1K
5.0K sh · $4.82
Own -2%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$3.2K
608 sh · $5.20
Own -0%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$7.9K
1.6K sh · $4.96
Own -1%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$16.2K
3.4K sh · $4.76
Own -1%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$4.8K
1.0K sh · $4.76
Own -0%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$17.4K
3.7K sh · $4.68
Own -1%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$9.2K
1.9K sh · $4.74
Own -1%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$13.5K
2.8K sh · $4.84
Own -1%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$11.7K
2.4K sh · $4.87
Own -1%
-
SOPH Sell·S
Chief Medical Officer · 10b5-1
$13.1K
2.7K sh · $4.85
Own -1%
-
SOPH Grant·A
Chief Medical Officer
$0
164.7K sh
Own New
-
SOPH Grant·A
Chief Medical Officer
$0
112.9K sh
Own New
-
SOPH Grant·A
Chief Medical Officer
$0
164.7K sh
Own New
-
SOPH Grant·A
Chief Medical Officer
$0
112.9K sh
Own +65%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | SOPH | Sell S | 5.0K | $24.8K |
| May 26, 2026 | SOPH | Sell S | 5.0K | $24.8K |
| May 19, 2026 | SOPH | Sell S | 608 | $2.8K |
| May 12, 2026 | SOPH | Sell S | 5.0K | $23.3K |
| Apr 27, 2026 | SOPH | Sell S | 5.0K | $24.1K |
| Apr 20, 2026 | SOPH | Sell S | 608 | $3.2K |
| Apr 14, 2026 | SOPH | Sell S | 1.6K | $7.9K |
| Apr 13, 2026 | SOPH | Sell S | 3.4K | $16.2K |
| Apr 13, 2026 | SOPH | Sell S | 1.0K | $4.8K |
| Apr 10, 2026 | SOPH | Sell S | 3.7K | $17.4K |
| Apr 9, 2026 | SOPH | Sell S | 1.9K | $9.2K |
| Apr 8, 2026 | SOPH | Sell S | 2.8K | $13.5K |
| Apr 7, 2026 | SOPH | Sell S | 2.4K | $11.7K |
| Apr 6, 2026 | SOPH | Sell S | 2.7K | $13.1K |
| Apr 2, 2026 | SOPH | Grant A | 164.7K | $0 |
| Apr 2, 2026 | SOPH | Grant A | 112.9K | $0 |
| Apr 2, 2026 | SOPH | Grant A | 164.7K | $0 |
| Apr 2, 2026 | SOPH | Grant A | 112.9K | $0 |
About Philippe Menu
This profile aggregates every SEC Form 4 insider transaction reported by Philippe Menu across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.